Elite in Subcutaneous Emphysema

Timm Greulich

Marburg An Der Lahn, HE, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Elite in Subcutaneous Emphysema
Marburg An Der Lahn, HE, DE 
OverviewLocationsClinical Research

Overview

Timm Greulich practices in Marburg An Der Lahn, Germany. Mr. Greulich is rated as an Elite expert by MediFind in the treatment of Subcutaneous Emphysema. His top areas of expertise are Emphysema, Subcutaneous Emphysema, Alpha-1 Antitrypsin Deficiency (AATD), and Chronic Obstructive Pulmonary Disease (COPD).

His clinical research consists of co-authoring 99 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 29 articles in the study of Subcutaneous Emphysema.

Gender
Male

Locations

Marburg An Der Lahn, HE, Germany
Other Locations
Giessen, HE, Germany
Germany
Grosshansdorf, SH, Germany
Heidelberg, BW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An International Multi-centre Prospective Cohort Study in Patients Hospitalized for an Acute Exacerbation of COPD
An International Multi-centre Prospective Cohort Study in Patients Hospitalized for an Acute Exacerbation of COPD
Enrollment Status: Recruiting
Publish Date: November 15, 2024
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
Enrollment Status: Completed
Publish Date: October 15, 2025
Intervention Type: Biological, Drug, Device
Study Drugs: Depemokimab, Mepolizumab, Benralizumab
Study Phase: Phase 3
View 1 Less Clinical Trial

99 Total Publications

Sex-Differences in Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry.
Sex-Differences in Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry.
Journal: Archivos de bronconeumologia
Published: May 16, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Greulich's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile